Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:20 pm Purchase |
2024-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,523,511 8.600% |
258,547 (+4.13%) |
Filing History |
| 2024-09-03 4:15 pm Purchase |
2024-09-03 | 13D | Ultralife Corporation ULBI |
WHITMORE BRADFORD T | 6,197,741 37.300% |
659,668 (+11.91%) |
Filing History |
| 2024-09-03 4:11 pm Unchanged |
2024-09-03 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 49,826,805 71.300% |
0 (Unchanged) |
Filing History |
| 2024-06-26 4:50 pm Unchanged |
2024-06-25 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 49,826,805 71.300% |
0 (Unchanged) |
Filing History |
| 2024-03-05 4:11 pm Purchase |
2024-03-01 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 49,826,805 71.500% |
15,000,000 (+43.07%) |
Filing History |
| 2024-02-12 5:07 pm Purchase |
2024-02-08 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 34,826,805 63.700% |
3,818,527 (+12.31%) |
Filing History |
| 2023-11-16 09:03 am Purchase |
2023-11-13 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 31,008,278 62.400% |
730,124 (+2.41%) |
Filing History |
| 2023-11-01 4:04 pm Purchase |
2023-10-27 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,264,964 10.100% |
247,112 (+4.11%) |
Filing History |
| 2023-01-04 12:06 pm Purchase |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,017,852 9.900% |
139,655 (+2.38%) |
Filing History |
| 2022-01-24 4:03 pm Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 5,878,197 9.900% |
-486,989 (-7.65%) |
Filing History |
| 2021-12-23 4:01 pm Purchase |
2021-12-21 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 30,278,154 62.100% |
95,555 (+0.32%) |
Filing History |
| 2021-01-07 11:10 am Purchase |
2021-01-06 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,365,186 11.100% |
929,845 (+17.11%) |
Filing History |
| 2020-11-06 2:38 pm Purchase |
2020-10-29 | 13D | Ultralife Corporation ULBI |
WHITMORE BRADFORD T | 5,538,073 34.800% |
395,347 (+7.69%) |
Filing History |
| 2020-11-06 2:21 pm Unchanged |
2020-10-29 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 30,182,599 62.700% |
0 (Unchanged) |
Filing History |
| 2020-10-01 4:47 pm Unchanged |
2020-09-29 | 13D | Nanophase Technologies Corporation NANX |
WHITMORE BRADFORD T | 30,182,599 62.700% |
0 (Unchanged) |
Filing History |